LANGLEBIGE POLYPEPTIDBINDUNGSMOLEKÜLE

Patent europeic · EP2820047 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2820047
Numer da la dumonda
EP13716734
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-03-2013
Publitgà
07-01-2015
Concedì
25-04-2018
La protecziun finescha il pli tard
28-02-2033
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07K 16/28 (2006.01)
Prioritad
US 201261605681 P 01.03.2012
US 201261606268 P 02.03.2012
Dumonda PCT
PCT/EP2013/054223 01.03.2013
Publicaziun PCT
WO2013/128027 06.09.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 25-04-2018

    Concedì

    Published in Swissreg on 25.04.2018

Partidas

Possessur

Amgen Research (Munich) GmbH

Staffelseestrasse 2, 81477 München, DE

Inventur

KUFER, Peter

81477 Munich, DE

RAUM, Tobias

81477 Munich, DE

LUTTERBUESE, Ralf

81477 Munich, DE

HOFFMANN, Patrick

81477 Munich, DE

MUENZ, Markus

81477 Munich, DE

BROZY, Johannes

81477 Munich, DE

KVESIC, Majk

81477 Munich, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.